A novel nonsense mutation in CEP290 induces exon skipping and leads to a relatively mild retinal phenotype

Investigative Ophthalmology & Visual Science
Karin W LittinkAnneke I den Hollander

Abstract

PURPOSE. To identify the genetic defect in a family with variable retinal phenotypes. The proband had a diagnosis of Leber congenital amaurosis (LCA), whereas her two cousins had an early-onset severe retinal dystrophy (EOSRD) with useful vision. A distant family member had retinitis pigmentosa (RP). METHODS. DNA samples of the affected family members were genotyped with 250 K genome-wide SNP microarrays. Genetic defects were localized by linkage analysis and homozygosity mapping, and candidate genes were analyzed by sequencing. Patients underwent a full ophthalmic examination. RESULTS. Compound heterozygous mutations in CEP290 were identified in the proband and her two cousins: the frequent c.2991+1655A>G founder mutation and a novel nonsense mutation in exon 7 (c.451C>T, p.Arg151X). The proband had nystagmus, hyperopia, a flat electroretinogram (ERG), and decreased visual acuity (20/250) from birth. The two cousins had minimal scotopic ERG responses at the age of 2. In one of these patients, visual acuity had reached a level of 20/32 at age 5, which is high for patients with CEP290 mutations. Analysis of the CEP290 mRNA in affected individuals revealed altered splice forms in which either exon 7 or exons 7 and 8 were skipped....Continue Reading

Citations

Dec 25, 2012·Tetrahedron·Anushree Kamath, Iwao Ojima
Jul 31, 2012·Human Molecular Genetics·Alejandro Estrada-CuzcanoDorus A Mans
Feb 16, 2012·Human Mutation·Kornelia NevelingHans Scheffer
Aug 7, 2010·Human Mutation·Frauke CoppietersElfride De Baere
Sep 2, 2015·Molecular Therapy. Nucleic Acids·Xavier GérardJean-Michel Rozet
Jun 13, 2015·Science Translational Medicine·Theodore G DrivasJean Bennett
Jun 13, 2015·Science Translational Medicine·Jean-Michel Rozet, Xavier Gérard
May 3, 2014·Organogenesis·Jarema Malicki, Tomer Avidor-Reiss
Apr 26, 2016·American Journal of Human Genetics·Sylvie GerberLucas Fares Taie
Aug 18, 2016·European Journal of Human Genetics : EJHG·Glen R MonroeGijs van Haaften
Aug 23, 2017·Genes·Susanne RoosingL Ingeborgh van den Born
Sep 1, 2017·Veterinary Ophthalmology·Andrea Louise MinellaSimon Michael Petersen-Jones
Aug 15, 2018·Investigative Ophthalmology & Visual Science·Mays TalibCamiel J F Boon
Sep 8, 2018·Investigative Ophthalmology & Visual Science·Dyon ValkenburgRob W J Collin
Nov 28, 2018·Investigative Ophthalmology & Visual Science·Frans P M CremersGaluh D N Astuti
Nov 18, 2018·Proceedings of the National Academy of Sciences of the United States of America·Simon A RamsbottomJohn A Sayer
Jul 5, 2016·Nature Reviews. Nephrology·Marijn F StokmanAlbertien M van Eerde
Oct 24, 2019·Nucleic Acids Research·Pora KimXiaobo Zhou
Feb 17, 2015·World Journal of Clinical Cases·Oscar Francisco Chacon-Camacho, Juan Carlos Zenteno
Jul 12, 2017·F1000Research·Elisa MolinariSimon A Ramsbottom
Jun 9, 2020·Asia-Pacific Journal of Ophthalmology·Mays Talib, Camiel J F Boon
Oct 28, 2020·Genes·Agnieszka RafalskaMarta Misiuk-Hojło
Mar 28, 2021·Pharmacology & Therapeutics·Max Duong PhuMelanie Philipp
Apr 4, 2021·International Journal of Molecular Sciences·Suzanne E de BruijnSusanne Roosing
Jul 31, 2021·Frontiers in Cell and Developmental Biology·Belén García BohórquezJosé M Millán
Jun 23, 2021·Journal of Cell Science·Magdalena Cardenas-RodriguezIain A Drummond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.